Eimerl J, Feuerstein G
Neuropeptides. 1986 Nov-Dec;8(4):351-8. doi: 10.1016/0143-4179(86)90006-5.
Opioid peptides and opioid receptors are found in the hearts of various species. Opioid peptides were also shown to modulate norepinephrine inducing changes in atrial rate, in vitro. Since we have recently shown a predominance of kappa and delta receptors in the rat atria, we found it of interest to study the role of highly selective opioid agonists on spontaneous and sympathetically stimulated heart rate. The pithed, artificially ventillated rat was used in these studies. D-Ala2-D-Leu5-enkephalin (DADL), was used as an delta-agonist, D-Ala2-MePhe4-Gly-ol5-enkephalin (DAGO) as a highly selective mu-agonist; Dynorphin A (1-17) as a kappa-agonist and beta-endorphin (beta-END) as a mixed epsilon-delta-mu agonist. Naloxone was used as an opiate antagonist. None of the above opioid peptides changed the basal blood pressure and heart rate at 1-100 nmol/kg except Dyn A-(1-17) which produced a brief depressor response (-15 +/- 2 mmHg, p less than 0.01). Stimulation of the spinal cord (50 v, 1 msec, 1 Hz, 30 sec) produced consistant pressor and cardiac accelerating responses. None of the opioid peptides studied blocked or enhanced the increase in blood pressure or heart rate produced by spinal cord stimulation. The depressor effect of the high dose of Dyn A-(1-17) was not blocked by naloxone. These results suggest that mu, delta or kappa opioid receptors in the rat heart have no role in the regulation of basal or sympathetically driven heart rate. Our data also suggest no role for these opioid receptors in modulation of basal arterial tone or norepinephrine-induced arteriolar constriction.
在多种物种的心脏中都发现了阿片肽和阿片受体。体外实验还表明,阿片肽可调节去甲肾上腺素诱导的心房率变化。由于我们最近发现大鼠心房中κ和δ受体占优势,因此我们有兴趣研究高选择性阿片激动剂对自发和交感神经刺激心率的作用。这些研究使用了脊髓横断、人工通气的大鼠。D-丙氨酸2-D-亮氨酸5-脑啡肽(DADL)用作δ激动剂,D-丙氨酸2-甲基苯丙氨酸4-甘氨醇5-脑啡肽(DAGO)用作高选择性μ激动剂;强啡肽A(1-17)用作κ激动剂,β-内啡肽(β-END)用作ε-δ-μ混合激动剂。纳洛酮用作阿片拮抗剂。除强啡肽A-(1-17)产生短暂的降压反应(-15±2 mmHg,p<0.01)外,上述阿片肽在1-100 nmol/kg剂量下均未改变基础血压和心率。刺激脊髓(50 V,1毫秒,1赫兹,30秒)产生持续的升压和心率加快反应。所研究的阿片肽均未阻断或增强脊髓刺激引起的血压或心率升高。高剂量强啡肽A-(1-17)的降压作用未被纳洛酮阻断。这些结果表明,大鼠心脏中的μ、δ或κ阿片受体在基础或交感神经驱动心率的调节中不起作用。我们的数据还表明,这些阿片受体在基础动脉张力或去甲肾上腺素诱导的小动脉收缩的调节中也不起作用。